Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawkes, C. J.
Right arrow Articles by Hutton, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawkes, C. J.
Right arrow Articles by Hutton, J. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 9 1187-1192, Copyright © 1996 by American Diabetes Association


ARTICLES

Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2

CJ Hawkes, C Wasmeier, MR Christie and JC Hutton
Department of Medicine, King's College School of Medicine and Dentistry, London, UK.

Antibodies to islet cell proteins detected as 37,000 and 40,000 M(r), tryptic fragments (37- and 40-kDa antigens) are strongly associated with progression to IDDM. The 40-kDa antigen has recently been identified as the tyrosine phosphatase-like protein IA-2 (ICA512) whereas the 37-kDa antigen has been suggested to be a different protein that has structural similarity to IA-2. A protein, phogrin, that has 80% amino acid sequence identity to IA-2 in the cytoplasmic domain, has recently been cloned from an insulinoma cell cDNA library. In this study, we have investigated possible relationships between the 37-kDa antigen and phogrin. Antibodies to phogrin were detected in sera from patients with IDDM, and these antibodies were strongly correlated with the presence of antibodies to the 37-kDa antigen. Trypsin treatment of immunoprecipitated phogrin generated a 37,000 M(r) fragment. Recombinant phogrin was able to block autoantibody binding to the 37-kDa antigen but not to the 40-kDa antigen, and rabbit antibodies raised to different regions of phogrin depleted insulinoma cell extracts specifically of the 37-kDa antigen. These results demonstrate that the 37-kDa antigen in IDDM is indistinguishable from phogrin and show that two distinct tyrosine phosphatase-related proteins are major targets of the autoimmune response in the disease.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Br Med BullHome page
K. L. Mehers and K. M. Gillespie
The genetic basis for type 1 diabetes
Br. Med. Bull., December 1, 2008; 88(1): 115 - 129.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Wenzlau, K. Juhl, L. Yu, O. Moua, S. A. Sarkar, P. Gottlieb, M. Rewers, G. S. Eisenbarth, J. Jensen, H. W. Davidson, et al.
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
PNAS, October 23, 2007; 104(43): 17040 - 17045.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. S. Wong, L. Wen, M. Tang, M. Ramanathan, I. Visintin, J. Daugherty, L. G. Hannum, C. A. Janeway Jr, and M. J. Shlomchik
Investigation of the Role of B-Cells in Type 1 Diabetes in the NOD Mouse
Diabetes, October 1, 2004; 53(10): 2581 - 2587.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
C. Roberts, G. A. Roberts, K. Löbner, M. Bearzatto, A. Clark, E. Bonifacio, and M. R. Christie
Expression of the Protein Tyrosine Phosphatase-like Protein IA-2 During Pancreatic Islet Development
J. Histochem. Cytochem., June 1, 2001; 49(6): 767 - 776.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini
Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes
J. Immunol., December 15, 2000; 165(12): 6748 - 6755.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Pilon, X.-R. Peng, A. M. Spence, R. H.A. Plasterk, and H.-M. Dosch
The Diabetes Autoantigen ICA69 and Its Caenorhabditis elegans Homologue, ric-19, Are Conserved Regulators of Neuroendocrine Secretion
Mol. Biol. Cell, October 1, 2000; 11(10): 3277 - 3288.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Bonifacio, V. Lampasona, and P. J. Bingley
IA-2 (Islet Cell Antigen 512) Is the Primary Target of Humoral Autoimmunity Against Type 1 Diabetes-Associated Tyrosine Phosphatase Autoantigens
J. Immunol., September 1, 1998; 161(5): 2648 - 2654.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Dotta, M. Previti, M. Neerman-Arbez, S. Dionisi, D. Cucinotta, L. Lenti, U. Di Mario, and P. A. Halban
The GM2-1 Ganglioside Islet Autoantigen in Insulin-Dependent Diabetes Mellitus Is Expressed in Secretory Granules and Is Not {beta}-Cell Specific
Endocrinology, January 1, 1998; 139(1): 316 - 319.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Borg, P. Fernlund, and G. Sundkvist
Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus
Clin. Chem., December 1, 1997; 43(12): 2358 - 2363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.